Corcept Therapeutics
CORT
#2480
Rank
A$8.99 B
Marketcap
$85.88
Share price
-0.30%
Change (1 day)
121.59%
Change (1 year)

Earnings for Corcept Therapeutics (CORT)

Earnings in 2024 (TTM): A$0.21 Billion

According to Corcept Therapeutics 's latest financial reports the company's current earnings are A$0.62 Billion. In 2023 the company made an earning of A$0.16 Billion a decrease over its 2022 earnings that were of A$0.17 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Corcept Therapeutics from 2003 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) A$0.21 B28.85%
2023 A$0.16 B-4.75%
2022 A$0.17 B-9.51%
2021 A$0.19 B-2.91%
2020 A$0.19 B14.87%
2019 A$0.17 B24.71%
2018 A$0.13 B69.32%
2017 A$81.16 M419.26%
2016 A$15.63 M-395.64%
2015 -A$5.29 Million-87.53%
2014 -A$42.42 Million-33.44%
2013 -A$63.73 Million
2011 -A$49.66 Million17.84%
2010 -A$42.14 Million35.5%
2009 -A$31.1 Million2.84%
2008 -A$30.24 Million60.81%
2007 -A$18.81 Million-52.14%
2006 -A$39.29 Million20.91%
2005 -A$32.5 Million31.87%
2004 -A$24.65 Million60.54%
2003 -A$15.35 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
A$28.24 B 12,731.42%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$10.57 Billion-4,899.14%๐Ÿ‡บ๐Ÿ‡ธ USA
A$19.55 B 8,781.20%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
A$15.58 B 6,980.48%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$1.87 Billion-945.43%๐Ÿ‡บ๐Ÿ‡ธ USA
A$25.32 B 11,402.59%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$62.5 Million-128.39%๐Ÿ‡บ๐Ÿ‡ธ USA
A$21.32 M-90.31%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.60 B 173.06%๐Ÿ‡บ๐Ÿ‡ธ USA